| Characteristic . | CG . | MP Group . | MP + AE Group . | P . |
|---|---|---|---|---|
| Age, y | 49.9 (6.6) | 49.0 (7.4) | 51.6 (4.2) | .42 |
| Body mass, kg | 79.9 (16.7) | 78.1 (20.3) | 74.3 (16.6) | .60 |
| Height, cm | 158.6 (7.3) | 160.9 (4.7) | 157.4 (6.4) | .21 |
| BMI, kg/m2 | 31.6 (5.7) | 30.0 (7.3) | 29.9 (5.6) | .63 |
| SBP rest, mm Hg | 118.5 (7.4) | 117.7 (8.4) | 122.2 (10.5) | .24 |
| DBP rest, mm Hg | 76.3 (10.5) | 76.4 (6.9) | 76.9 (9.1) | .97 |
| MBP rest, mm Hg | 90.4 (7.6) | 90.2 (6.6) | 92.0 (8.4) | .70 |
| HR rest, bpm | 70.9 (8.1) | 71.2 (12.6) | 68.7 (8.6) | .68 |
| DP rest, mm Hg × bpm | 8386.5 (893.1) | 8356.6 (1353.9) | 8403.2 (1353.0) | .99 |
| Postmenopause, yes/no, no. of participants | 14/6 | 14/6 | 15/5 | |
| Antihypertensive drugs, % of participants | ||||
| Diuretics | 55.0 | 50.0 | 70.0 | |
| Calcium channel blockers | 20.0 | 10.0 | 25.0 | |
| Beta-blockers | 20.0 | 40.0 | 35.0 | |
| Antagonists of angiotensin II receptor | 80.0 | 85.0 | 60.0 | |
| ACE inhibitors | 15.0 | 5.0 | 0 | |
| Risk factors/diseases, % of participants | ||||
| Diabetics mellitus | 25.0 | 20.0 | 20.0 | |
| Dyslipidemia | 50.0 | 40.0 | 35.0 | |
| Smoking | 5.0 | 0 | 0 |
| Characteristic . | CG . | MP Group . | MP + AE Group . | P . |
|---|---|---|---|---|
| Age, y | 49.9 (6.6) | 49.0 (7.4) | 51.6 (4.2) | .42 |
| Body mass, kg | 79.9 (16.7) | 78.1 (20.3) | 74.3 (16.6) | .60 |
| Height, cm | 158.6 (7.3) | 160.9 (4.7) | 157.4 (6.4) | .21 |
| BMI, kg/m2 | 31.6 (5.7) | 30.0 (7.3) | 29.9 (5.6) | .63 |
| SBP rest, mm Hg | 118.5 (7.4) | 117.7 (8.4) | 122.2 (10.5) | .24 |
| DBP rest, mm Hg | 76.3 (10.5) | 76.4 (6.9) | 76.9 (9.1) | .97 |
| MBP rest, mm Hg | 90.4 (7.6) | 90.2 (6.6) | 92.0 (8.4) | .70 |
| HR rest, bpm | 70.9 (8.1) | 71.2 (12.6) | 68.7 (8.6) | .68 |
| DP rest, mm Hg × bpm | 8386.5 (893.1) | 8356.6 (1353.9) | 8403.2 (1353.0) | .99 |
| Postmenopause, yes/no, no. of participants | 14/6 | 14/6 | 15/5 | |
| Antihypertensive drugs, % of participants | ||||
| Diuretics | 55.0 | 50.0 | 70.0 | |
| Calcium channel blockers | 20.0 | 10.0 | 25.0 | |
| Beta-blockers | 20.0 | 40.0 | 35.0 | |
| Antagonists of angiotensin II receptor | 80.0 | 85.0 | 60.0 | |
| ACE inhibitors | 15.0 | 5.0 | 0 | |
| Risk factors/diseases, % of participants | ||||
| Diabetics mellitus | 25.0 | 20.0 | 20.0 | |
| Dyslipidemia | 50.0 | 40.0 | 35.0 | |
| Smoking | 5.0 | 0 | 0 |
aData are reported as mean (SD) unless otherwise indicated. ACE = angiotensin-converting enzyme; BMI = body mass index; bpm = beats per minute; CG = control group; DP rest = double product at rest; DBP rest = diastolic blood pressure at rest; HR rest = heart rate at rest; MBP rest = mean blood pressure at rest; MP = mat Pilates; MP + AE = mat Pilates supplemented with aerobic exercise; SBP rest = systolic blood pressure at rest.
| Characteristic . | CG . | MP Group . | MP + AE Group . | P . |
|---|---|---|---|---|
| Age, y | 49.9 (6.6) | 49.0 (7.4) | 51.6 (4.2) | .42 |
| Body mass, kg | 79.9 (16.7) | 78.1 (20.3) | 74.3 (16.6) | .60 |
| Height, cm | 158.6 (7.3) | 160.9 (4.7) | 157.4 (6.4) | .21 |
| BMI, kg/m2 | 31.6 (5.7) | 30.0 (7.3) | 29.9 (5.6) | .63 |
| SBP rest, mm Hg | 118.5 (7.4) | 117.7 (8.4) | 122.2 (10.5) | .24 |
| DBP rest, mm Hg | 76.3 (10.5) | 76.4 (6.9) | 76.9 (9.1) | .97 |
| MBP rest, mm Hg | 90.4 (7.6) | 90.2 (6.6) | 92.0 (8.4) | .70 |
| HR rest, bpm | 70.9 (8.1) | 71.2 (12.6) | 68.7 (8.6) | .68 |
| DP rest, mm Hg × bpm | 8386.5 (893.1) | 8356.6 (1353.9) | 8403.2 (1353.0) | .99 |
| Postmenopause, yes/no, no. of participants | 14/6 | 14/6 | 15/5 | |
| Antihypertensive drugs, % of participants | ||||
| Diuretics | 55.0 | 50.0 | 70.0 | |
| Calcium channel blockers | 20.0 | 10.0 | 25.0 | |
| Beta-blockers | 20.0 | 40.0 | 35.0 | |
| Antagonists of angiotensin II receptor | 80.0 | 85.0 | 60.0 | |
| ACE inhibitors | 15.0 | 5.0 | 0 | |
| Risk factors/diseases, % of participants | ||||
| Diabetics mellitus | 25.0 | 20.0 | 20.0 | |
| Dyslipidemia | 50.0 | 40.0 | 35.0 | |
| Smoking | 5.0 | 0 | 0 |
| Characteristic . | CG . | MP Group . | MP + AE Group . | P . |
|---|---|---|---|---|
| Age, y | 49.9 (6.6) | 49.0 (7.4) | 51.6 (4.2) | .42 |
| Body mass, kg | 79.9 (16.7) | 78.1 (20.3) | 74.3 (16.6) | .60 |
| Height, cm | 158.6 (7.3) | 160.9 (4.7) | 157.4 (6.4) | .21 |
| BMI, kg/m2 | 31.6 (5.7) | 30.0 (7.3) | 29.9 (5.6) | .63 |
| SBP rest, mm Hg | 118.5 (7.4) | 117.7 (8.4) | 122.2 (10.5) | .24 |
| DBP rest, mm Hg | 76.3 (10.5) | 76.4 (6.9) | 76.9 (9.1) | .97 |
| MBP rest, mm Hg | 90.4 (7.6) | 90.2 (6.6) | 92.0 (8.4) | .70 |
| HR rest, bpm | 70.9 (8.1) | 71.2 (12.6) | 68.7 (8.6) | .68 |
| DP rest, mm Hg × bpm | 8386.5 (893.1) | 8356.6 (1353.9) | 8403.2 (1353.0) | .99 |
| Postmenopause, yes/no, no. of participants | 14/6 | 14/6 | 15/5 | |
| Antihypertensive drugs, % of participants | ||||
| Diuretics | 55.0 | 50.0 | 70.0 | |
| Calcium channel blockers | 20.0 | 10.0 | 25.0 | |
| Beta-blockers | 20.0 | 40.0 | 35.0 | |
| Antagonists of angiotensin II receptor | 80.0 | 85.0 | 60.0 | |
| ACE inhibitors | 15.0 | 5.0 | 0 | |
| Risk factors/diseases, % of participants | ||||
| Diabetics mellitus | 25.0 | 20.0 | 20.0 | |
| Dyslipidemia | 50.0 | 40.0 | 35.0 | |
| Smoking | 5.0 | 0 | 0 |
aData are reported as mean (SD) unless otherwise indicated. ACE = angiotensin-converting enzyme; BMI = body mass index; bpm = beats per minute; CG = control group; DP rest = double product at rest; DBP rest = diastolic blood pressure at rest; HR rest = heart rate at rest; MBP rest = mean blood pressure at rest; MP = mat Pilates; MP + AE = mat Pilates supplemented with aerobic exercise; SBP rest = systolic blood pressure at rest.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
